Antipsychotic efficacy and motor tolerability in a phase III placebo-controlled study of pimavanserin in patients with Parkinson's Disease psychosis (Acp-103-020).

Saved in:
Bibliographic Details
Title: Antipsychotic efficacy and motor tolerability in a phase III placebo-controlled study of pimavanserin in patients with Parkinson's Disease psychosis (Acp-103-020).
Authors: Cummings, J.1, Isaacson, S.2, Mills, R.3, Williams, H.3, Chi-Burris, K.3, Dhall, R.4, Ballard, C.5
Source: Journal of the Neurological Sciences. Oct2013, Vol. 333, pe119-e120. 0p.
Database: Academic Search Ultimate
Description
ISSN:0022510X
DOI:10.1016/j.jns.2013.07.401